CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 18 filers reported holding CARDIOME PHARMA CORP in Q3 2013. The put-call ratio across all filers is 4.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,000 | +100.0% | 917 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 917 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -94.1% | 917 | -87.7% | 0.00% | – |
| Q2 2017 | $34,000 | -52.8% | 7,441 | -68.8% | 0.00% | -100.0% |
| Q1 2017 | $72,000 | +148.3% | 23,870 | +123.7% | 0.00% | – |
| Q4 2016 | $29,000 | -84.0% | 10,670 | -81.5% | 0.00% | -100.0% |
| Q3 2016 | $181,000 | +4425.0% | 57,770 | +8358.3% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 683 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -86.4% | 683 | -74.9% | 0.00% | – |
| Q4 2015 | $22,000 | -79.0% | 2,722 | -78.0% | 0.00% | -100.0% |
| Q3 2015 | $105,000 | -85.2% | 12,397 | -83.5% | 0.00% | -90.0% |
| Q2 2015 | $708,000 | +237.1% | 75,222 | +232.0% | 0.01% | +233.3% |
| Q1 2015 | $210,000 | +3400.0% | 22,656 | +3246.5% | 0.00% | – |
| Q4 2014 | $6,000 | -90.0% | 677 | -90.0% | 0.00% | -100.0% |
| Q3 2014 | $60,000 | -78.5% | 6,741 | -81.0% | 0.00% | -75.0% |
| Q2 2014 | $279,000 | +54.1% | 35,421 | +54.6% | 0.00% | +33.3% |
| Q1 2014 | $181,000 | -47.1% | 22,905 | -58.2% | 0.00% | -40.0% |
| Q4 2013 | $342,000 | +362.2% | 54,815 | +160.2% | 0.01% | +400.0% |
| Q3 2013 | $74,000 | – | 21,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|